Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells

There has recently been a paradigm shift in the field of dendritic cell (DC)-based immunotherapy, where several clinical studies have confirmed the feasibility and advantageousness of using directly isolated human blood-derived DCs over in vitro differentiated subsets. There are two major DC subsets...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Immunol Immunother
Egile Nagusiak: Sköld, Annette E., Mathan, Till S. M., van Beek, Jasper J. P., Flórez-Grau, Georgina, van den Beukel, Michelle D., Sittig, Simone P., Wimmers, Florian, Bakdash, Ghaith, Schreibelt, Gerty, de Vries, I. Jolanda M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132867/
https://ncbi.nlm.nih.gov/pubmed/30019146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2204-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak